Nuvation Bio Inc. Class A (NUVB) Key Ratios
$6.64
As on 01-Sep-2026 16:20EDT
Market cap
$2,398 Mln
Revenue (TTM)
$170 Mln
P/E Ratio
--
P/B Ratio
10
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -61.93 | 555.64 | 1,083.56 | 862.45 | -- |
| EBIT | -563.29 | 4.28 | 36.11 | -17.03 | -55.98 |
| Net Profit | -1,264.35 | -6.50 | 26.16 | -30.01 | -180.56 |
| EPS | -1,360.32 | -4.05 | 30.69 | -1.76 | -4.17 |
| Book Value | -- | -- | -35.50 | -33.35 | -11.22 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -3,756.49 | -3,756.49 | -76.04 | -303.56 | -7,209.42 |
| Net Margin
| -- | -990.33 | -88.19 | -- | -- |
| Return on equity
| -57.16 | -40.89 | -53.55 | -53.18 | -106.27 |
| Return on Capital
| -56.28 | -40.33 | -- | -51.90 | -105.00 |
| Return on Assets
| -48.50 | -35.46 | -19.40 | -36.04 | -97.74 |
| Debt to Equity (x)
| -- | -- | 0.96 | 0.03 | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
-51.90
|
-105.00
|
-11.95
|
-14.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-53.55
Lower than Peers by 13.15
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-53.55
|
-53.18
|
-106.27
|
-12.03
|
-14.87
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-19.40
Higher than Peers by 11.58
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-19.40
|
-36.04
|
-97.74
|
-11.72
|
-14.39
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-76.04
Higher than Peers by 7.58
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-76.04
|
-303.56
|
-7,209.42
|
--
|
--
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-88.19
Higher than Peers by 4.48
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-88.19
|
-325.31
|
-7,213.76
|
--
|
-670.74
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
1,083.56
Higher than Peers by 1,029.61
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
1,083.56
|
6.99
|
--
|
--
|
--
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
36.11
Higher than Peers by 36.91
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
36.11
|
66.36
|
-648.79
|
27.25
|
-19.98
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
26.16
Higher than Peers by 33.46
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
26.16
|
63.97
|
-649.24
|
27.25
|
-19.98
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
30.69
Higher than Peers by 16.04
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
30.69
|
0.65
|
-3.87
|
0.27
|
-0.11
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-33.49
Lower than Peers by 23.31
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-33.49
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.96
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
0.96
|
0.03
|
0.02
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.03
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
0.03
|
0.02
|
0.02
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
8.37
Higher than Peers by 2.56
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
8.37
|
6.95
|
9.04
|
44.11
|
50.70
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
8.14
Higher than Peers by 2.45
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
8.14
|
6.81
|
9.04
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-4.62
Lower than Peers by 2.53
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
-4.62
|
-13.96
|
-1,664.51
|
--
|
-11.38
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.67
Lower than Peers by 0.47
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
18.67
|
30.78
|
206.94
|
--
|
--
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.22
Higher than Peers by 0.16
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
0.22
|
0.11
|
0.01
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
103.51
|
463.79
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
246.85
|
--
|
--
|
485,302.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
342.38
|
220.79
|
3,576.82
|
2,288.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
7.98
|
243.00
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
-15.08
|
-1.58
|
-4.36
|
-4.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
10.04
Higher than Peers by 4.86
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
10.04
|
10.09
|
1.93
|
0.55
|
0.64
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
2.23
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
2.23
|
-13.56
|
-0.71
|
3.66
|
2.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2,398
Higher than Peers by 2,252
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nuvation Bio Inc. Class A (NUVB)
|
2,398
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|